Skip to main content
OpenTrials
Completed

NCT Number: NCT03875599

Measuring Self-Efficacy on Portuguese Respiratory Patients on Pulmonary Rehabilitation

This study aimed to translate and adapt to portuguese an original british instrument useful to measure respiratory patients' self-efficacy specific to the context of Pulmonary Rehabilitation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

26 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória, Lisbon, Portugal

Loading trial locations.

About this study

Recent updates on Pulmonary Rehabilitation highlight the importance of patients' self-efficacy on long-term adherence to health-enhancing behaviors. The Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) is an adaptation of the General Self-Efficacy Scale. This study aimed to translate, culturally adapt and evaluate reliability and validity of PRAISE on Portuguese respiratory patients.Forward-backward translation and pilot testing were performed. Content validity was assessed by a multidisciplinary panel of expert judges. To evaluate reliability and validity, 150 respiratory outpatients on Pulmonary Rehabilitation participated on a cross-sectional study. Descriptive and reliability analyses, and exploratory factorial analysis using principal axis factoring, followed by oblique oblimin factor rotation were conducted to identify construct validity. IBM® SPSS® version 22 was used to perform statistical analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with acute respiratory disease
  • Patients with chronic respiratory disease
  • Patients attending a hospital-based Pulmonary Rehabilitation program

Exclusion criteria

  • Cognitive deficit for answering a questionnaire

Treatment and study plan

Pulmonary Rehabilitation

Other

Respiratory Physiotherapy, Exercise Therapy, Patient Education

Primary outcomes

  1. Patients' self-efficacy

    Time frame: 2 weeks

    Vincent and co-authors (2011) proposed the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE). The PRAISE tool is composed by a total of 15 items, combining 10 items from the General Self-Efficacy Scale (GSE) by Schwarzer and Jerusalem (1995), and 5 new specific items related to Pulmonary Rehabilitation. Each item is scored from 1 to 4 with a total range from 15 to 60, with higher scores indicating higher levels of self-efficacy. Araújo and Moura (2011) already validated a Portuguese version of the GSE, yet the assessment of self-efficacy remains to be explored on the Portuguese Pulmonary Rehabilitation setting. This study translated, culturally adapted and evaluated reliability and validity of PRAISE on Portuguese respiratory patients, with original author's permission. Hence, items 4, 7, 9, 12 and 15 were specific to Pulmonary Rehabilitation as proposed by PRAISE original authors, and the remaining items and answer key were in accordance with the portuguese GSE.

Sponsors and collaborators

Lead sponsor

University of Lisbon

Other

Collaborators

  • Centro Hospitalar Lisboa Norte
  • Fundação para a Ciência e a Tecnologia

Registry information

Official study title

Validation of the Pulmonary Rehabilitation Adapted Index of Self-Efficacy on Portuguese Respiratory Patients

Acronym: PRAISEPort

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Mar 15, 2019
Registry last updated
Mar 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.